Zobrazeno 1 - 10
of 43
pro vyhledávání: '"T. Gionfra"'
Autor:
Francesca Conti, Patrizia Vici, P. Foggi, Luigi Di Lauro, Franca Belli, A. Amodio, A. Ferraironi, Claudio Botti, Massimo Lopez, T. Gionfra, Maria Francesca Morelli
Publikováno v:
Oncology. 60:60-65
Objective: To better determine docetaxel activity in patients with well-defined anthracycline-resistant breast cancer. Methods: From October 1996, we carried out a phase II trial in 69 heavily pretreated patients with advanced breast cancer with doce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20a00ac9a3ac79b465cb59d2265ed63c
https://doi.org/10.1159/000055298
https://doi.org/10.1159/000055298
Autor:
Luigi Di Lauro, A. Amodio, Patrizia Vici, Franca Belli, Francesca Conti, Massimo Lopez, T. Gionfra
Publikováno v:
Oncology. 58:3-7
Based on preclinical data showing a synergistic activity of simultaneous administration of vinorelbine and paclitaxel, we carried out a phase II trial in previously untreated advanced breast cancer patients. Treatment consisted of vinorelbine 25 mg/m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35c7005be1764f82885cefdfca4eeb7f
https://doi.org/10.1159/000012071
https://doi.org/10.1159/000012071
Autor:
T. Gionfra, L. Di Lauro, Patrizia Vici, Francesco Pignatti, G. Paoletti, Silvia Carpano, M. Lopez, F. Conti, Diana Giannarelli
Publikováno v:
European Journal of Cancer. 31:1611-1614
The aim of this study was to determine if lonidamine (LND) supplementation to single-agent epirubicin (EPI) could reverse anthracycline resistance in patients with metastatic breast cancer. 45 patients with metastatic breast cancer were treated with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3fbfcef545b7ac3af03dc92538760d6
https://doi.org/10.1016/0959-8049(95)00200-3
https://doi.org/10.1016/0959-8049(95)00200-3
Autor:
Silvia Carpano, M. Lopez, L. Di Lauro, P Del Medico, T. Gionfra, M. Rosselli, Patrizia Vici, A. Cancrini
Publikováno v:
Scopus-Elsevier
To determine the activity of sequential administration of thymopentin (TP-5), interferon alpha-2a (IFN) and interleukin-2 (IL-2) in metastatic renal cell cancer (RCC), 17 patients with RCC were treated with TP-5 50 mg/d on days 1 to 14, IFN 3 MIU/d o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cf0e8e6bd65d572074deac3d4b24e65
https://doi.org/10.1177/030089169508100110
https://doi.org/10.1177/030089169508100110
Autor:
A, Amodio, S, Carpano, C, Manfredi, G, Del Monte, L, Di Lauro, T, Gionfra, F, Conti, G, Paoletti, M, Lopez
Publikováno v:
La Clinica terapeutica. 150(1)
To assess the activity and toxicity of gemcitabine in locally advanced or metastatic soft tissue sarcoma patients (pts).Gemcitabine was administered on days 1, 8, 15 every 4 weeks at a dose of 1.000/1.250 mg/m2, respectively, in pretreated or not pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a3c80e6802942e33ae8867ee6274f457
https://pubmed.ncbi.nlm.nih.gov/10367540
https://pubmed.ncbi.nlm.nih.gov/10367540
Autor:
M, Lopez, S, Carpano, A, Amodio, T, Gionfra, M, Della Giulia, P, Foggi, C, Manfredi, G, Del Monte
Publikováno v:
La Clinica terapeutica. 149(5)
The objective of this trial was to assess the therapeutic activity and toxicity of ifosfamide (IFO) with mesna uroprotection as salvage therapy in patients (pts) with soft tissue sarcomas (STS) who had failed high-dose epirubicin treatment.IFO was ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4ab56ea381982b3502445df5a3eca196
https://pubmed.ncbi.nlm.nih.gov/10052244
https://pubmed.ncbi.nlm.nih.gov/10052244
Publikováno v:
La Clinica terapeutica. 149(4)
To evaluate the activity and toxicity of simultaneous infusion of vinorelbine (VNB) and paclitaxel (T) as first line chemotherapy in advanced breast cancer patients (pts).33 pts with histologically proven advanced breast cancer were treated with VNB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::645e5f7c446a10b99398af1915ee5be2
https://pubmed.ncbi.nlm.nih.gov/9866885
https://pubmed.ncbi.nlm.nih.gov/9866885
Publikováno v:
La Clinica terapeutica. 149(2)
To evaluate the activity and toxicity of docetaxel (TXT) as second line therapy in advanced soft-tissue sarcoma.Adult patients (pts) with histologically proven locally advanced or metastatic soft tissue sarcoma, were treated with TXT at a dose of 100
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::60929679290bec8d3778b9a907924360
https://pubmed.ncbi.nlm.nih.gov/9780476
https://pubmed.ncbi.nlm.nih.gov/9780476
Autor:
G, Paoletti, L, Di Lauro, T, Gionfra, I, Venturo, F, Belli, E, Squilloni, S, Mariotti, G, Fioretti, M, Gemini, R, Tersigni, M, Lopez
Publikováno v:
La Clinica terapeutica. 149(2)
To evaluate the efficacy and toxicity of a sequential low-dose methotrexate (MTX) and 5-fluorouracil (5FU) regimen in the palliative treatment of patients with advanced colorectal cancer.Enrolled in the study were patients with advanced colorectal ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9ce8ab99ca9eafef5b3fe1df5f802b07
https://pubmed.ncbi.nlm.nih.gov/9780473
https://pubmed.ncbi.nlm.nih.gov/9780473
Publikováno v:
Journal of experimentalclinical cancer research : CR. 16(3)
Twenty-six cancer patients (pts) with chemotherapy-related neutropenic fever were treated with vancomycin 30 mg/m2/day i.v. every 12 hrs, imipenem 1500 mg/day i.v. every 8 hrs, and pefloxacin 800 mg/day i.v. every 12 hrs. Twelve fevers of unknown ori
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cf2d4660b05ebb960827e4a745e5cb45
https://pubmed.ncbi.nlm.nih.gov/9387908
https://pubmed.ncbi.nlm.nih.gov/9387908